The ability of an anti-interleukin-23 antibody to bind to key immune system components may help neutralize a key driver of inflammation right at its cellular source.
Dan Cua, PhD
Advertisement
Articles by Dan Cua, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
Walgreens Strengthens Vaccine Access Through Digital Tools, Pharmacist Education
3
Transforming HER2+ Metastatic Breast Cancer Treatment With Targeted ADC Therapy
4
Subcutaneous Amivantamab Shows Promise in EGFR-Mutated Lung Cancer
5
